Top-News

Acceleron Pharma News

Aktie
WKN:  A1W5LE ISIN:  US00434H1086 US-Symbol:  XLRN
Keine aktuellen Kursdaten verfügbar
Handeln Depot/Watchlist
Dieses Wertpapier ist nicht mehr handelbar.
Aktienanzahl *
61,12 Mio.
Marktkapitalisierung *
-
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 29.10.2021

Acceleron Pharma News

04.11.21 - PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates ROG, RRD, XLRN, ADMS; Shareholders are Encouraged to Contact the Firm
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates ROG, RRD, XLRN, ADMS; Shareholders are Encouraged to Contact the Firm PR Newswire
01.11.21 - PR Newswire
SHAREHOLDER ALERT: WeissLaw LLP Reminds DWSN, PAE, XLRN, and FLXN Shareholders About Its Ongoing Investigations
SHAREHOLDER ALERT: WeissLaw LLP Reminds DWSN, PAE, XLRN, and FLXN Shareholders About Its Ongoing Investigations PR Newswire
01.11.21 - PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates ZEN, KRA, HFC, INOV, KOR, XLRN; Shareholders are Encouraged to Contact the Firm
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates ZEN, KRA, HFC, INOV, KOR, XLRN; Shareholders are Encouraged to Contact the Firm PR Newswire
27.10.21 - PR Newswire
SHAREHOLDER ALERT: WeissLaw LLP Reminds COLB, XLRN, ACBI. and ECHO Shareholders About Its Ongoing Investigations
SHAREHOLDER ALERT: WeissLaw LLP Reminds COLB, XLRN, ACBI. and ECHO Shareholders About Its Ongoing Investigations PR Newswire
26.10.21 - PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates KRA, ESBK, CXP, KOR, XLRN; Shareholders are Encouraged to Contact the Firm
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates KRA, ESBK, CXP, KOR, XLRN; Shareholders are Encouraged to Contact the Firm PR Newswire
22.10.21 - PR Newswire
SHAREHOLDER ALERT: WeissLaw LLP Reminds MDP, GWB, XLRN and HFC Shareholders About Its Ongoing Investigations
SHAREHOLDER ALERT: WeissLaw LLP Reminds MDP, GWB, XLRN and HFC Shareholders About Its Ongoing Investigations PR Newswire
18.10.21 - PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates UMPQ, DSPG, JMP, KOR, XLRN, VNE; Shareholders are Encouraged to Contact the Firm
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates UMPQ, DSPG, JMP, KOR, XLRN, VNE; Shareholders are Encouraged to Contact the Firm PR Newswire
13.10.21 - PR Newswire
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Acceleron Pharma Inc. - XLRN
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Acceleron Pharma Inc. - XLRN PR Newswire
13.10.21 - PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates XLRN, AZPN, UMPQ, TGP; Shareholders are Encouraged to Contact the Firm
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates XLRN, AZPN, UMPQ, TGP; Shareholders are Encouraged to Contact the Firm PR Newswire
07.10.21 - PR Newswire
SHAREHOLDER ALERT: WeissLaw LLP Reminds XLRN, JMP, ECHO, and KDMN Shareholders About Its Ongoing Investigations
SHAREHOLDER ALERT: WeissLaw LLP Reminds XLRN, JMP, ECHO, and KDMN Shareholders About Its Ongoing Investigations PR Newswire
01.10.21 - PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates XLRN, ADTN, DSPG, KDMN; Shareholders are Encouraged to Contact the Firm
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates XLRN, ADTN, DSPG, KDMN; Shareholders are Encouraged to Contact the Firm PR Newswire
30.09.21 - Der Aktionär
Milliarden‑Deal fix: Merck & Co übernimmt Acceleron Pharma
30.09.21 - PR Newswire
Shareholder Alert: Ademi LLP investigates whether Acceleron Pharma Inc. has obtained a Fair Price in its transaction with Merck
Shareholder Alert: Ademi LLP investigates whether Acceleron Pharma Inc. has obtained a Fair Price in its transaction with Merck PR Newswire
27.09.21 - PR Newswire
Thinking about trading options or stock in Pfizer, Callon Petroleum, Acceleron Pharma, Tesla, or Expedia Group?
Thinking about trading options or stock in Pfizer, Callon Petroleum, Acceleron Pharma, Tesla, or Expedia Group? PR Newswire
26.09.21 - Der Aktionär
Übernahme‑Hammer voraus? Diese Biotech‑Gesellschaft steht hoch im Kurs
06.07.20 - PR Newswire
XLRN Investor Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Acceleron Pharma Inc. and Encourages Investors to Contact the Firm
XLRN Investor Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Acceleron Pharma Inc. and Encourages Investors to Contact the Firm PR Newswire
20.02.20 - PR Newswire
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Acceleron Pharma Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Acceleron Pharma Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors PR Newswire
28.01.20 - sharedeals.de
Acceleron Pharma: Bluthochdruck!
Die Aktie von Acceleron Pharma (WKN: A1W5LE) gehört heute zu den ganz großen Gewinnern am US-​Aktienmarkt und kann um sage und schreibe mehr als +50% zulegen. Dabei ...
28.01.20 - PR Newswire
Thinking about buying stock in Advanced Micro Devices, Ford, FuelCell Energy, Pinterest, or Acceleron Pharma?
Thinking about buying stock in Advanced Micro Devices, Ford, FuelCell Energy, Pinterest, or Acceleron Pharma? PR Newswire
28.01.20 - Finanztrends
Acceleron Pharma: Bluthochdruck!
Die Aktie von Acceleron Pharma (WKN: A1W5LE) gehört heute zu den ganz großen Gewinnern am US-​Aktienmarkt und kann um sage und schreibe mehr als +50% zulegen.

Newssuche

Videos

newspaper
03.05.24 -13,45%
Technical Trading: Gold freitags Long
Gold Long Typ: Turbo Open End WKN: NG8DB8 Hebel: 27 Laufzeit: OpenEnd Einstieg: Market ... Mehr »